Simple jQuery Dropdowns

Browsing by Author Piyawat Komolmit

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)
22-Apr-2016Efficacy of telbivudine with conditional tenofovir intensification in patients with chronic hepatitis B: Results from the 2-year roadmap strategyTeerha Piratvisuth; Piyawat Komolmit; Henry L.Y. Chan; Tawesak Tanwandee; Wattana Sukeepaisarnjaroen; Mário G. Pessoa; Eduardo Fassio; Suzane K. Ono; Fernando Bessone; Jorge Daruich; Stefan Zeuzem; Michael Manns; Alkaz Uddin; Yuhong Dong; Aldo Trylesinski; Prince of Songkla University; Chulalongkorn University; Chinese University of Hong Kong; Mahidol University; Khon Kaen University; Universidade de Sao Paulo - USP; Hospital Nacional Professor Dr. Alejandro Posadas; Universidad Nacional de Rosario; Hospital de Clinicas Jose de San Martin; Klinikum und Fachbereich Medizin Johann Wolfgang Goethe-Universität Frankfurt am Main; Medizinische Hochschule Hannover (MHH); Novartis Pharmaceuticals Corporation; Novartis International AG
24-Jun-2009Patterns of managing chronic hepatitis B treatment-related drug resistance: A survey of physicians in Mainland China, South Korea, Taiwan, and ThailandSiwaporn Chainuvati; Jun Cheng; Jin Lin Hou; Chao Wei Hsu; Ji Dong Jia; Piyawat Komolmit; So Young Kwon; Chang Hong Lee; Hong Li; Ying Li; Chun Jen Liu; Boon Leong Neo; Cheng Yuan Peng; Tawesak Tanwandee; Suchat Wongcharatrawee; Jaw Ching Wu; Ming Lung Yu; Xin Xin Zhang; Mahidol University; Beijing Ditan Hospital; Southern Medical University; Chang Gung University College of Medicine; Capital Medical University China; Chulalongkorn University; Konkuk University, College of Medicine; Bristol-Myers Squibb; National Taiwan University; China Medical University Hospital Taichung; National Yang-Ming University, School of Medicine; Kaohsiung Medical University Chung-Ho Memorial Hospital; Kaohsiung Medical University; Ruijin Hospital
1-Nov-2016Treatment outcomes and validation of the stopping rule for response to peginterferon in chronic hepatitis B: A Thai nationwide cohort studyPhunchai Charatcharoenwitthaya; Wattana Sukeepaisarnjaroen; Teerha Piratvisuth; Satawat Thongsawat; Theeranun Sanpajit; Soonthorn Chonprasertsuk; Woramon Jeamsripong; Ekawee Sripariwuth; Piyawat Komolmit; Tanisa Patcharatrakul; Rattana Boonsirichan; Chalermrat Bunchorntavakul; Supoj Tuntipanichteerakul; Tawesak Tanwandee; Mahidol University; Khon Kaen University; Prince of Songkla University; Chiang Mai University; Phramongkutklao College of Medicine; Faculty of Medicine, Thammasat University; Buddhachinaraj Hospital; Naresuan University; Chulalongkorn University; Police General Hospital; Vajira Hospital; Rajavithi Hospital; Bhumibol Adulyadej Hospital